| Christopher Wolf, DPM | |
|
175 Carew Street, #250, Springfield, MA 01104 | |
| (413) 748-7350 | |
| (413) 748-7325 |
| Full Name | Christopher Wolf |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 8 Years |
| Location | 175 Carew Street, Springfield, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093178709 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 2492 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Medical Ctr | Springfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverbend Medical Group Inc | 5698064343 | 159 |
News Archive
Researchers involved in the GISSI trial, concluded that simple, safe and cheap treatment with n-3 PUFA can provide a moderate beneficial advantage in terms of mortality and admission to hospital for cardiovascular reasons in patients with chronic heart failure, in a context of usual care.
Individuals traveling across East Africa on Friday were ordered to begin receiving mandatory yellow fever vaccines in an effort "to contain an outbreak of the disease in Uganda," which has sickened an estimated 190 people, resulting in 48 deaths as of Dec. 30, 2010, the Citizen reports (Ubwani, 1/22).
Cell Therapeutics, Inc. ("CTI") announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology ("ASH") Annual Meeting updated results from the pivotal phase III EXTEND (PIX 301) clinical trial of pixantrone (the "PIX 301 EXTEND trial") in relapsed or refractory, aggressive non-Hodgkin's lymphoma ("NHL") patients who have failed 2 or more prior therapies.
Supplemental child restraints should be used by all children through age 8. When appropriate child safety restraint systems-based on a child's age and weight-are in use during motor vehicle crashes, the rates of mortality and serious injury significantly decrease. Most parents don't know that their older children-ages 4 to 8-should use additional measures to protect them from serious injury or death in case of a crash.
› Verified 7 days ago
| Provider Name | Riverbend Medical Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1841651197 PECOS PAC ID: 5698064343 Enrollment ID: O20160614001710 |
News Archive
Researchers involved in the GISSI trial, concluded that simple, safe and cheap treatment with n-3 PUFA can provide a moderate beneficial advantage in terms of mortality and admission to hospital for cardiovascular reasons in patients with chronic heart failure, in a context of usual care.
Individuals traveling across East Africa on Friday were ordered to begin receiving mandatory yellow fever vaccines in an effort "to contain an outbreak of the disease in Uganda," which has sickened an estimated 190 people, resulting in 48 deaths as of Dec. 30, 2010, the Citizen reports (Ubwani, 1/22).
Cell Therapeutics, Inc. ("CTI") announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology ("ASH") Annual Meeting updated results from the pivotal phase III EXTEND (PIX 301) clinical trial of pixantrone (the "PIX 301 EXTEND trial") in relapsed or refractory, aggressive non-Hodgkin's lymphoma ("NHL") patients who have failed 2 or more prior therapies.
Supplemental child restraints should be used by all children through age 8. When appropriate child safety restraint systems-based on a child's age and weight-are in use during motor vehicle crashes, the rates of mortality and serious injury significantly decrease. Most parents don't know that their older children-ages 4 to 8-should use additional measures to protect them from serious injury or death in case of a crash.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Wolf, DPM 175 Carew St Ste 250, Springfield, MA 01104-2483 Ph: (413) 748-7350 | Christopher Wolf, DPM 175 Carew Street, #250, Springfield, MA 01104 Ph: (413) 748-7350 |
News Archive
Researchers involved in the GISSI trial, concluded that simple, safe and cheap treatment with n-3 PUFA can provide a moderate beneficial advantage in terms of mortality and admission to hospital for cardiovascular reasons in patients with chronic heart failure, in a context of usual care.
Individuals traveling across East Africa on Friday were ordered to begin receiving mandatory yellow fever vaccines in an effort "to contain an outbreak of the disease in Uganda," which has sickened an estimated 190 people, resulting in 48 deaths as of Dec. 30, 2010, the Citizen reports (Ubwani, 1/22).
Cell Therapeutics, Inc. ("CTI") announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology ("ASH") Annual Meeting updated results from the pivotal phase III EXTEND (PIX 301) clinical trial of pixantrone (the "PIX 301 EXTEND trial") in relapsed or refractory, aggressive non-Hodgkin's lymphoma ("NHL") patients who have failed 2 or more prior therapies.
Supplemental child restraints should be used by all children through age 8. When appropriate child safety restraint systems-based on a child's age and weight-are in use during motor vehicle crashes, the rates of mortality and serious injury significantly decrease. Most parents don't know that their older children-ages 4 to 8-should use additional measures to protect them from serious injury or death in case of a crash.
› Verified 7 days ago
Foot Specialists Associates Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 1786 Wilbraham Rd, Springfield, MA 01119 Phone: 413-783-0114 Fax: 413-783-3661 | |
Kyle W Bruce, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 305 Bicentennial Hwy, Springfield, MA 01118 Phone: 413-733-4101 Fax: 413-598-7876 | |
Dr. Patrick Matthew Jones, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 780 Chestnut St, Suite 8, Springfield, MA 01107 Phone: 413-736-3225 Fax: 413-736-3382 | |
Dr. James H Courniotes Ii, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1786 Wilbraham Road, Springfield, MA 01119 Phone: 413-783-0114 Fax: 413-783-3661 | |
Dr. Charles F Ross, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 25 Bond St, Springfield, MA 01104 Phone: 134-731-6041 | |
Benjamin C. Dickert, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 222 Carew St, Ste 101, Springfield, MA 01104 Phone: 413-736-3225 Fax: 413-736-3382 |